Rigel Pharmaceuticals reported $-18403000 in Operating Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Agenus AGEN:US USD -41645000 2.92M
Amgen AMGN:US USD 2.74B 562M
Anika Therapeutics ANIK:US USD 11.69M 15.07M
Arrowhead Research ARWR:US USD -83830000 10.92M
AstraZeneca AZN:LN USD 1.25B 706M
Astrazeneca AZN:US USD 1.25B 706M
Biomarin Pharmaceutical BMRN:US USD -2417000 41.57M
Bristol Myers Squibb BMY:US USD 2.47B 117M
Celldex Therapeutics CLDX:US USD -27696000 8.7M
Daiichi Sankyo 4568:JP JPY 61.2B 26.82B
Eli Lilly And LLY:US USD 1.68B 466.4M
Halozyme Therapeutics HALO:US USD 80.58M 46.52M
Heron Therapeutics HRTX:US USD -41882000 7.62M
Immunogen IMGN:US USD -77429000 16.38M
Intrexon XON:US USD -7614000 16.55M
Karyopharm Therapeutics KPTI:US USD -30839000 12.07M
Ligand Pharmaceuticals LGND:US USD 636K 695K
Macrogenics MGNX:US USD -24955000 16.85M
Neurocrine Biosciences NBIX:US USD 87.8M 103.1M
Pfizer PFE:US USD 9.41B 2.69B
Regeneron Pharmaceuticals REGN:US USD 1.22B 113.8M
Rigel Pharmaceuticals RIGL:US USD -18403000 5.44M
Sangamo Biosciences SGMO:US USD -54894000 9.16M
Ultragenyx Pharmaceutical RARE:US USD -225066000 83.47M
Veracyte VCYT:US USD -9680000 1.05M